NCCR-Synapsy

The Synaptic Bases of Mental Diseases

Women researchers win Synapsy poster awards

The poster session of the eleventh annual meeting of the NCCR-Synapsy took place at the Diabrlerets Convention Center on the evening of Thursday, October 14. Peter Uhlhaas, representative of the Synapsy Advisory Board, generously agreed to serve as a member Read more…


Daniella Dwir’s study awarded prize

Daniella Dwir, researcher in the laboratory of Kim Do at the Schizophrenia Research Unit of the Center for Psychiatric Neurosciences of the CHUV, won the “Young investigator award” of the Swiss Society of Biological Psychiatry (SSBP) during its 2021 annual Read more…


Invitation for entries for the Research prize of the Swiss Brain League

Every two years, the Swiss Brain League awards a prize of CHF 20,000 to a Swiss research group in recognition of its outstanding scientific contribution in the field of neurological research. Both clinical and basic research projects are eligible. The Read more…


Best wishes for 2021

The Management Team wishes You all the Best for the New Year!


Johannes Gräff promoted to associate professor

Graeff June18

Prof. Johannes Gräff, Synapsy principal investigator, has been promoted to Associate Professor of Life Sciences at the School of Life Sciences at EPFL. At its meeting of 23/24 September 2020 and upon application of the President of ETH Zurich, Professor Read more…


Confined planet: a challenge for women

Following the WHO’s announcement on the coronavirus pandemic, our planet entered several weeks of confinement. Since then, the scientific community has been studying the consequences of this health crisis, particularly on women. As women are in the majority in the Read more…


Death of Prof. Alexandre Dayer, NCCR Synapsy director

Dear members of the Synapsy community, It is with great sadness that I have to inform you of the tragic passing of our NCCR Synapsy Director, colleague and friend Alexandre. His passing leaves a huge void in our hearts, our Read more…


Gliapharm completes a CHF 2 Million financing to advance its drug development program

GliaPharm SA has completed a CHF 2 million financing. The company is initially focusing on an orphan neurological disease caused by a deficiency in brain metabolism that affects more than 100’000 children around the world from an early age through Read more…


Optimus Agora Prize for Carmen Sandi and Dominique de Quervain

Dominique de Quervain and Carmen Sandi are being awarded Optimus Agora Prize. Their project “Stress” encourages interaction with the public. Stress is part of everyday life. Better understanding it, and knowing how to prevent situations that cause it, improves our Read more…